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cient (ADC)Abstract Purpose: To detect axillary lymph node metastasis based on diffusion Weighted MR
and apparent diffusion coefﬁcient (ADC) in the known breast cancer cases.
Patient and methods: Forty-four patients were included in this study for preoperative MRI staging
of the breast cancer and axillary lymph node assessment. The lymph node criteria (long/short-axis
ratio, T2WI, DWI and ADC value) were included in the analysis. Images were obtained with dif-
fusion sensitizing gradients of 0 and 750 mm2/s. The ADC was calculated.
Results: Thirty-two patients had metastatic axillary lymph nodes and 12 cases had no malignant LN
involvement. There was no signiﬁcant difference between both in S/L ratio, T2WISI (p< 0.140 &
p= 0.079, respectively), while statistically signiﬁcant difference between benign and malignant
lymph nodes in both DWI and ADC mean values (p< 0.0001 & p< 0.007, respectively). The opti-
mal ADC cut off value was 6.8 · 103 mm2/s for differentiation between benign and malignant
lymph nodes with accuracy 96.7%, sensitivity 100%, speciﬁcity 87%, PPV 95.4% and NPV 100%.
Conclusion: Compared with lymph node size or routine magnetic resonance sequences, DWI and
ADC are promising techniques for differentiating metastatic and non metastatic axillary lymph
nodes in known breast cancer patients.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine. Open access under CC BY-NC-ND license.1. Introduction
Axillary lymph node involvement is the most common route of
breast cancer metastases, and is an essential prognostic factor
and an important determinant in the treatment of patients with
breast cancer (1–4). Axillary lymph node dissection with histo-
pathological examination of the surgical specimen is regarded
as the gold standard for detecting involvement of the lymph
nodes (1,2).
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talization, general anesthesia, and a 1- to 2-week period of
postoperative drain care (5,6). The effect of axillary lymph
node dissection on long-term treatment results in invasive
breast cancer is controversial; it is in fact frequently questioned
because it is associated with high morbidity rates and neoadju-
vant chemotherapy is already administered in aggressive local
cancers (7).
With magnetic resonance imaging (MRI), computed
tomography, and ultrasonography techniques, the preopera-
tive assessment of axillary lymph node status is mainly based
on the measurement of nodal dimensions, such as maximum
long-axis diameter, short-axis diameter or long/short-axis
ratio, but these techniques are somewhat limited. In addition,
morphologic criteria (e.g., shape, thickened lobular cortex, dis-
placement and/or absence of fatty hilum), enhancement pat-
terns, and grouping of lymph nodes are further important
parameters (8–11). All these criteria remain controversial,
and recommendations for differentiation between metastatic
and non-metastatic lymph nodes vary widely.
Diffusion-weighted imaging (DWI) facilitates the noninva-
sive characterization of various tissues on the basis of their
water diffusion properties. Any architectural changes in the
proportion of extracellular to intracellular water protons will
alter the diffusion coefﬁcient of the tissue (12–14), thus provid-
ing information about the biophysical properties of tissues
in vivo. Quantitative measurement of apparent diffusion coef-
ﬁcient (ADC) could reﬂect the degree of restriction of diffusion
of different tissues (15,16).
In the present study, we aimed to determine metastatic axil-
lary lymph node involvement by a simple and noninvasive
method with focus on the feasibility of DWI technique to
detect metastatic lymph nodes in pathologically proven breast
cancer patients.
2. Patients and methods
2.1. Patients
From July 2011 to April 2013, 48 consecutive patients (age
range, 24–70 years) were included with histologically proven
breast cancer and pre-operative MRI for staging and detection
of axillary LN involvement. This study was approved by ethics
committee of the University, and all patients gave written
informed consent before being included. Four of these 48
patients were secondarily excluded for the following reasons:
pulmonary metastases detected on MRI (= n1), general health
unsuitable for surgery (= n1), cancelation of surgery by the
patient (= n1), and poor magnetic resonance (MR) image
quality related to motion-artifacts (= n1). Some cases had pre-
vious US examinations; we did not take these data and other
morphological criteria into account or include them in statisti-
cal analysis.
2.2. Magnetic resonance imaging protocol and related dynamic
data processing
Magnetic resonance imaging was performed on a 1.5 Tesla sys-
tem (Philips, Achivea –Class B-USA) with the patient in the
prone position and the breast suspended in 4 channel dedi-
cated breast coil. After obtaining an axial localizer sequence,axial T1-weighted images [turbo-spin echo (TSE); repetition
time (TR), 613 ms; echo time (TE), 9.1 ms; section thickness
(ST), 3.5 mm], axial short T1 inversion recovery (STIR)
sequences (TE: 9370 ms, TE: 70 ms, ST: 3.5 mm) were
acquired [ﬁeld of view (FOV): 400 · 350 mm].
For dynamic study a standard dose (0.1 mmol/kg) of con-
trast agent with gadolinium was injected through the antecubi-
tal vein in each patient immediately following the acquisition
of precontrast series. Following the injection of contrast agent,
15 mL physiological saline ﬂush was injected in each patient.
After the contrast injection, DCE-MRI was performed with
gradient-recalled sequences (TR, 4.4 ms; TE, 1.6 ms; ﬂip angle,
12; FOV, 350 · 350 mm, 256 · 128; section thickness 1.5 mm
with no section gap). Including those acquired during the pre-
contrast period, a total of 7 series each consisting of 80 consec-
utive images were acquired. In every 51 s six subtracted images
(image series achieved by subtracting the precontrast image
from each series) were transferred to the mean curve analysis
in the work station. After the dynamic study, sagittal late post-
contrast fat-saturated T1-weighted TSE images (TR, 532 ms;
TE, 4.01 ms; ST, 3.0 mm; FOV: 400 · 400 mm) were acquired
in order to recheck and correlate the lesions and axillary lymph
nodes.
DWI was performed using a diffusion-weighted echo planar
imaging (EPI) sequence with spectral spatial fat suppression
and parallel imaging (reduction factor = 2); TR/TE = 7000/
71.5 ms, 3 NEX, matrix = 192 · 192, bandwidth = 1953 Hz/
pixel, FOV= 36 cm, slice thickness = 5 mm, gap = 0. Diffu-
sion gradients were applied in six directions with b= 0 and
750 s/mm2, and the scan time was 160 s.
2.2.1. Measurements on MRI and image analysis
The axillary lymph nodes with the short-axis diameter equal to
or greater than 5 mm were included in our study. The long-axis
(L) and short-axis (S) diameters were measured on the corre-
sponding maximum section of each lymph node on axial
T2WI, respectively, and the long/short-axis ratio (L/S) was cal-
culated. The signal intensity on T2WI and DWI (ST2WI,
SDWI) of each selected lymph node was reported. The ADC
maps were calculated on a pixel-by-pixel basis. We used the
corresponding central slice of each lymph node on the ADC
map, a round or elliptical region of interest (ROI) covering
about 3/4 of the entire area of the selected lymph node
attempting to avoid inclusion of the margins; while T2W imag-
ing was used as the anatomical reference. The apparent diffu-
sion coefﬁcient (ADC) value was calculated for lymph nodes.
The area of the ROI in the selected axillary lymph nodes
was 25–150 mm2, according to their different sizes. For ADC
measurement, ROIs were placed in the LNs; all the values were
averaged from three-time measurements and expressed as the
mean ± standard deviation.
FNAB or/and true cut Biopsy was/were performed in dom-
inant lymph node or nodes visualized in images in all cases.
The dominant lymph nodes were identiﬁed according to the
following criteria: asymmetric cortical thickening, cortical
irregularity, cortical heterogeneity, hilar deformation and loss
of fatty sinus, and loss of ovality (rounding).
2.2.2. Statistical analysis
Statistical analyses were performed by using Statistical Prod-
uct and Service Solutions (SPSS, Version 15.0.1, Inc., Chicago,
Fig. 1 A 25 year old female patient with malignant left breast
mass and ﬁbroadenosis of the both breasts. (A) sagittal T2FS
image demonstrates the enlarged left axillary LNs (15 · 20, S/L
diameter), displaying rounded shape, thickened cortex and no
central fatty signal. (B and C) DWI & color coded ADC map
showing hypointense not restricted diffusion, ADC value of
prominent left axillary lymph node is measured 1.63 · 103 mm2/s
(arrow).
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between the axillary malignant and non malignant lymph
nodes were compared using independent t test. Fisher’s exact
test was also used to assess the relationship between both
groups’ signal intensity appearance on T2WI (SIT2WI) and
signal intensity on DWI (SIDWI). A p value <0.05 was con-
sidered statistically signiﬁcant.
3. Results
In the present study the patients’ age ranged from 24 to
70 years (mean 54 years). Among the 44 cases, dominant
lymph nodes were evaluated consisting of 32 (72.7%) meta-
static and 12 (27.2%) non malignant lymph nodes. Of thirty-
two metastatic cases, 8 (25%) of the cases were bilateral and
unilateral in 24 (75%) of the cases, while non malignant lymph
nodes were bilateral in 3 cases and unilateral in 9 cases. The
pathological results for 32 malignant breast cases were as fol-
lows: 21 invasive ductal carcinoma, 10 diagnosed as lobular
carcinoma, and 1 medullary carcinoma. Regarding the 12
benign cases 5 of them were inﬂammatory and the other 7
cases were non speciﬁc enlargement.
The mean values of L/S ratio for the axillary benign (Fig. 1)
and metastatic (Figs. 2 and 3) lymph nodes were 2.1 ±
0.12 mm, 1.6 ± 0.13 mm, respectively (table 1). Depending
on the S/L ratio between the malignant and benign LNs there
was no statistically signiﬁcant difference. Depending on the
signal intensity criteria on T2WI and signal-intensity of
the LNs in DWI, there was no signiﬁcant difference between
the signal intensity of benign and metastatic L.Ns on T2 WI
(p= 0.079), however, there was a statistically signiﬁcant
difference between non malignant and malignant LNs
(p< 0.001) in DWI (Figs. 1 and 2, respectively).
The mean value of the ADC for the axillary metastatic LNs
(Figs. 2 and 3) is lower (0.79 ± 0.23 · 103 mm2/s) than mean
AD values for benign lymph nodes (1. 42 ± 0.57 · 103 mm2/
s) (ﬁg. 1). The difference between the two groups was statisti-
cally signiﬁcant (Table 1).
In this study, statistical analysis of our results showed that
optimal ADC cut off value for differentiation between benign
and malignant lymph nodes is 6.8 · 103 mm2/s with accuracy
96.7%, sensitivity 100%, speciﬁcity 87%, PPV 95.4% and
NPV 100%.
4. Discussion
Preoperative detection of axillary lymph node metastases is
desirable because in many settings it may allow a surgeon to
bypass sentinel lymph node biopsy (SLNB) and proceed
directly to complete axillary lymph node dissection (ALND),
sparing patients an additional operative procedure and expe-
diting their progression through their cancer treatment course
(17).
DCE-MRI is now performed routinely in patients newly
diagnosed with breast cancer at many institutions in preoper-
ative evaluation as it had advantages over sonographic evalu-
ation of the axilla which include the ability to compare directly
axillary lymph nodes in question with the contralateral axilla
and decreased dependence on operator experience. Unlike
the evaluation of primary tumors on MRI, enhancement kinet-
ics features have not proven useful for discrimination ofabnormal nodes because many normal nodes exhibit kinetics
features typical of breast malignancy (e.g., delayed washout)
(18).
As a simple, fast, non-invasive and non-contrast tool, diffu-
sion weighted imaging (DWI) has been the most potential rep-
resentative of fMRI in LN mapping in recent years (13,15).
We found that no statistically signiﬁcant difference between
malignant and benign LNs depending on the S/L ratio,
Fig. 2 A 42 year old female patient with malignant RT breast
mass. (A) T2FS image demonstrates the enlarged RT axillary LNs
(16 · 24 mm, S/L diameter), displaying oval shape, irregular
thickened cortex and no fatty hilum. (B and C) DWI & color
coded ADC map showing heterogeneous hyperintense signal and
restricted diffusion, ADC value of prominent RT axillary lymph
node is measured 0.78 · 103 mm2/s (arrow).
Fig. 3 A 48 year old female patient with malignant RT breast
mass and breast edema with skin thickening. (A) Axial T2FS
image demonstrates the enlarged RT axillary LNs (12 · 16 mm, S/
L diameter), displaying oval shape, irregular thickened cortex and
effaced faint fatty hilum. (B and C) DWI & color coded ADC map
showing heterogeneous hyperintense signal and restricted diffu-
sion, ADC value of the RT axillary lymph node is measured
0.81 · 103 mm2/s (arrow).
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curate differentiation between the metastatic and benign LNs
depending on the LN size and this criteria gave is low sensitiv-
ity in the diagnosis of metastatic nodes (53–62%). Moreover,
Obwegeser et al. (19) reported that, in histological analysisof 1249 axillary lymph nodes in 71 patients with breast cancer,
13.7% of metastatic nodes were 5–9 mm in short-axis diame-
ter. Also we found, there was no statistical difference between
axillary non metastatic and metastatic lymph nodes, regarding
their signal intensity on T2WI, in agreement with the results
obtained by Som (20).
In the present study the high signal intensity nodes on DWI
were signiﬁcantly higher than those on T2WI, the malignant
Table 1 Comparison of the results of the mean value for the lymph node S/L ratio, T2WI, DWI signal intensity and mean ADCs of
the metastatic and non malignant.
MRI criteria Malignant (n= 32, %) Non malignant (n= 12, %) p
The mean S/L ratio 1.6 ± 0.13 2.1 ± 0.12 p< 0.140b
SIT2WI
Hypointense 2/32, 6.2 6/12, 50 p= 0.079a
Hyperintense 28/32, 87.5 5/12, 41.6
Heterogeneous 2/32, 8.6 1/12, 8.3
SI-DWI (B= 750) p< 0.0001a
Hyperintense 31/32, 96.8 1/12, 8.3
Hypointense 1/32, 3.1 11/12, 91.6
Mean ADC (x103 mm2/s) 0.79 ± 0.23 1.42 ± 0.57 p< 0.007 b
L/S = long/short-axis ratio, SIT2WI = signal Intensity on T2WI, SI-DWI = signal intensity diffusion-weighted imaging ADC=mean
apparent diffusion coefﬁcient p value <0.05 was considered statistically signiﬁcant.
a Fisher’s exact test.
b Independent-t test.
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that made it easy to identify. Similar to Wang et al. (21)
ﬁndings in their study on rabbit models, stated that statistical
signiﬁcant difference comparing the signal intensity on T2 WI
and DWI between inﬂammatory and malignant L.Ns groups.
On the contrary Vandecaveye et al. (22), found that the
visual assessment of DWI to differentiate the axillary inﬂam-
matory from metastatic lymph nodes was rather a difﬁcult
task, as in some cases both groups’ lymph nodes showed high
signal intensities on DWI. The ADC values calculated from
DWI can provide quantitative analysis of microscopic water
diffusivity in the target tissues and can completely exclude
the T2 shine-through effect.
Among our patients lower ADC values were always
observed in metastatic lymph nodes and there was a statisti-
cally signiﬁcant difference in the ADC mean values between
metastatic and non- metastatic axillary L.Ns. We use the opti-
mal 6.8 · 103 mm2/s ADC cut off value for differentiation
between benign and malignant lymph nodes and this optimal
cut off recorded high accuracy 96.7%, sensitivity 100%, spec-
iﬁcity 87%, PPV 95.4% and NPV 100%. Near to our ﬁndings
Kim et al. (23) reported that ADC value can help to differen-
tiate malignant from benign LNs in predicting nodal metasta-
sis in head and neck cancer. Using threshold value of
0.85 · 103/mm2 s1, the accuracy, sensitivity and speciﬁcity
of ADC value for differential diagnosis are 91.0%, 91.3%
and 91.1%, respectively. They stated the reasons for a more
powerful diagnostic ability of DWI than other size-dependent
imaging methods because, normal size LNs with micrometas-
tasis are evaluated correctly and another is hyper plastic
benign nodes are appropriately excluded. Also, Isıl et al. (24)
found that, the ADC values of malignant lymph nodes were
signiﬁcantly lower than the benign ones (p= 0.001), but they
used 1.22 · 103 mm2/s as the cut-off ADC value, and
reported a sensitivity of 75.6% and a speciﬁcity of 71.1%.
On the other hand Wang et al., 17 had reported sensitivity,
speciﬁcity and accuracy, which were 86.2%, 79.3%, 81.2%,
when the rADC value (ADC lesion/ ADC reference site) was
chosen as 0.80.
Further studies with a large number of subjects will increase
conﬁdence in the results of DWI and guide physicians involved
in diagnosis, treatment and follow up of breast cancer patients.In conclusion: DWI and ADC values had high accuracy for
differentiating axillary non metastatic (benign) from metastatic
lymph nodes.Conﬂict of interest
None declared.
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